159 results
Page 3 of 8
8-K
EX-99.1
oawy6sk9a8phvuxedx
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
eotoz59fqs6h8c1
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
dne2tje
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
xx0swkuo2
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.1
1vskdy skl
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
fxs4hrk2ygfdi kf1
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
e8yqkl06mxjy4xba7g9b
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
rmjgo061n
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
7tfctc4vhg2i2rst
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.1
sxt46b rdp79guolc9
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
EX-99.1
syq5go4ut955pc2
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
a1j9ps x4l
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
haft77cyd6fp57sfi
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
s4llyak2hz7 x5v
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am